CAR-T cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes

Claire Lacan (1) , Jonathan Caron (2) , Nadine Tarantino (1) , Baptiste Fouquet (3) , Mustapha Cherai (3) , Christophe Parizot (3) , Véronique Morel (3) , Laetitia Souchet (3) , Madalina Uzunov (3) , Guy Gorochov (3) , Stéphanie Nguyen-Quoc (1) , Elise Sourdeau (3) , Vincent Vieillard (1) , Makoto Miyara (3) , Angélique Vinit (4) , Silvia Solorzano (3) , Carole Soussain (5) , Caroline Houillier (6) , Carole Metz (3) , Brigitte Autran (1) , Elena Litvinova (3) , Magali Le Garff-Tavernier (2, 3) , Françoise Norol (3) , Damien Roos-Weil (3) , Sylvan Choquet (3) , Amélie Guihot (1) , Marine Baron (1, 3)

1 CIMI - Centre d'Immunologie et des Maladies Infectieuses
2 CRC (UMR_S_1138 / U1138) - Centre de Recherche des Cordeliers
3 CHU Pitié-Salpêtrière [AP-HP]
4 PASS-CYPS - Cytométrie Pitié-Salpêtrière
5 ICSC - Institut Curie - Saint Cloud
6 ICM - Institut du Cerveau = Paris Brain Institute

Not available.

Domains: Human health and pathology

Claire Lacan, Jonathan Caron, Nadine Tarantino, Baptiste Fouquet, Mustapha Cherai, et al.. CAR-T cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes. Haematologica, 2023, ⟨10.3324/haematol.2023.282875⟩. ⟨hal-04348235⟩